Blockade of phencyclidine-induced effects by a nitric oxide donor

British Journal of Pharmacology

Volumn 130, Issue 5, 2000, Pages 1005-1012

  Bujas Bobanovic, M ^a   Bird, D C ^a   Robertson, H A ^a   Dursun, S M ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Ataxia; c fos; Locomotor activity; Neuronal activity; Nitric oxide; Phencyclidine; Rat; Sodium nitroprusside

Indexed keywords

NITRIC OXIDE; NITROPRUSSIDE SODIUM; PHENCYCLIDINE; PROTEIN C FOS;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATAXIA; BRAIN METABOLISM; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; MALE; NONHUMAN; PRIORITY JOURNAL; PSYCHOSIS; RAT; SCHIZOPHRENIA;

EID: 0033949502     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703406     Document Type: Article

References (80)

1. ANDREASEN, N.C. (1997). Linking mind and brain in the study of mental illnesses: A project for a scientific psychopathology. Science, 275, 1586-1593.
2. AUGER. A.P. & BLAUSTEIN. J.D. (1995). Progesterone enhances an estradiol-induced increase in fos immunoreactivity in localized regions of female rat forebrain. J. Neurosci., 15, 2272-2279.
3. AYATA, C , AYATA, G., HARA, H , MATTHEWS. R.T., BEAL, M F., FERRANTE. R.J., ENDRES, M., KIM, A., CHRISTIE, R.H., WAEBER, C.. HUANG, P.L., HYMAN, B.T. & MOSKOWITZ, M.A. (1997). Mechanisms of reduced striatal NMDA excitotoxicity in type 1 nitric oxide synthase knock-out mice. J. Neurosci., 17, 6908-6917.
4. BANNERMAN, D.M., CHAPMAN, P.F., KELLY, P.A T.. BUTCHER, S.P. & MORRIS, R.G.M. (1994a). Inhibition of nitric oxide synthase does not impair spatial learning. J. Neurosci., 14, 7404-7414.
5. BANNERMAN, D.M., CHAPMAN, P.F., KELLY. P.A.T., BUTCHER, S.P. & MORRIS, R.G.M. (1994b). Inhibition of nitric oxide synthase does not prevent the induction of long-term potentiation in vivo. J. Neurosci., 14, 7415-7425.
6. BÖHME, G.A., BON, C., LEMAIRE, M., REIBAUD, M , PIOT, O., STUTZMANN, J.M., DOBLE. A. & BLANCHARD. J.C. (1993). Altered synaptic plasticity and memory formation in nitric oxide synthase inhibitor-treated rats. Proc. Natl. Acad. Sci. U.S.A., 90, 9191-9194.
7. BUISSON, A., LAKHMECHE, N., VERRECCHIA, C.. PLOTKINE, M. & BOULU, R.G (1993). Nitric oxide: an endogenous anticonvulsant substance. Neuroreport, 4, 444-446.
8. BUJAS-BOBANOVIC, M., DURSUN, S.M. & ROBERTSON, H.A. (1998a). The dose-dependent effects of phencyclidine on behaviour and immediate-early genes in rats. Br. J. Pharmacol., 124, 70P.
9. BUJAS-BOBANOVIC, M., DURSUN, S.M. & ROBERTSON, H.A. (1998b). Nitric oxide synthase inhibitor 1-NAME enhances phencyclidine-induced behaviours and neural activation in rat brain. Br. J. Pharmacol., 124, 63P.
10. CARLSSON, A., SVENSSON, A. & CARLSSON, M.L. (1993). Future strategies in the discovery of new antipsychotic agents: focus on dopamine-glutamate interactions. In New Generation of Antipsychotic Drugs: Novel Mechanisms of Action. ed. Brunello, N., Mendlewicz. J. & Racagni, G. pp. 118-129, Basel: Basel.
11. CASTELLANI, S. & ADAMS, P M. (1981). Effects of dopaminergic drugs on phencyclidine-induced behavior in the rat. Neuropharmacology, 20, 371-374.
12. CHAPMAN, P.F., ATKINS. C.M.. ALLEN, M.T., HALEY, J.E. & STEINMETZ, J.E. (1992). Inhibition of nitric oxide synthesis impairs two different forms of learning. Neuroreport, 3, 567-570.
13. CHETTY, C.S., HUSSAIN, S., SLIKKER. W. & ALI, S F. (1995). Effects of phencyclidine on nitric oxide synthase activity in different regions of rat brain. Res. Comm. Alco. Subst. Abuse, 16, 105-114.
14. CONNOP, B.P., ROLFE, N.G., BOEGMAN, R.J., JHAMANDAS. K. & BENINGER, R.J. (1994). Potentiation of NMDA-mediated toxicity on nigrostriatal neurons by a low dose of 7-nitro indazole. Neuropharmacology, 33, 1439-1445.
15. DAWSON, V.L. & DAWSON, T M. (1996). Nitric oxide actions in neurochemistry. Neurochem. Int., 29, 97-110.
16. DAWSON, V.L.. DAWSON, T.M., BARTLEY, D.A , UHL, G.R. & SNYDER, S.H. (1993). Mechanisms of nitric oxide-induced neurotoxicity in primary brain cultures. J. Neurosci., 13, 2651-2661.
17. DOLAN, R.J.. FLETCHER, P., FRITH, C.D., FRISTON, K.J., FRACKOWIAK, R.S.J. & GRASBY, P.M. (1995). Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia. Nature, 378, 180-182.
18. DUNCAN, G.E., MOY, S.S., KNAPP, D.J., MUELLER, R.A. & BRESSE, G.R. (1998). Metabolic mapping of the rat brain after subanesthetic doses of ketamine: potential relevance to schizophrenia. Brain Res., 787, 181-190.
19. DZOLJIC, E.. DE VRIES, R & DZOLJIC, M.R. (1997). New and potent inhibitors of nitric oxide synthase reduce motor activity in mice. Behav. Brain Res., 87, 209-212.
20. FRENCH. L.D (1986). Effects of SKF 10,047, phencyclidine and other psychomotor stimulants in the rat following 6-hydroxydopamine lesion of the ventral tegmental area. Neuropharmacology. 25, 447-450.
21. 3H-glutamate binding to rat brain synaptic membranes. Brain Res., 554, 355-357.
22. GASS, P.. HERDEGEN, T., BRAVO, R. & KIESSLING, M. (1993). Induction and suppression of immediate early genes in specific rat brain regions by the non-competitive N-methyl-D-aspartate receptor antagonist MK-801. Neuroscience, 53, 749-759.
23. GATTAZ, W.F., CRAMER, H. & BECKMANN, H. (1984). Haloperidol increases the cerebrospinal fluid concentrations of cyclic GMP in schizophrenic patients. Biol. Psychiatry, 19, 1229-1235.
24. GOLDMAN-RAKIC, P.S. (1996). Memory: recording experience in cells and circuits: diversity in memory research. Proc. Natl. Acad. Sci. U.S.A., 93, 13435-13447.
25. GRAYBIEL, A.M., MORATELLA, R. & ROBERTSON, H.A. (1990). Amphetamine and cocaine induce drug-specific activation of the c-fos gene expression in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. Natl. Acad. Sci. U.S.A., 87, 6912-6916.
26. GREENBURG, B.D. & SEGAL, D.S. (1985). Acute and chronic behavioural interactions between PCP and amphetamine: evidence for a dopaminergic role in some PCP-induced behaviours. Pharmacol. Biochem. Behav., 23, 99-105.
27. HABERNY, K.A., POU, S. & ECCLES, C. (1992). Potentiation of quinolinate-induced hippocampal lesions by inhibition of NO synthesis. Neurosci. Lett., 146, 187-190.
28. HARDER, J.A.. ABOOBAKER, A.A., HODGETTS, T.C & RIDLEY. R.M. (1998). Learning impairments induced by glutamate blockade using dizocilpine (MK-801) in monkeys. Br. J. Pharmacol., 125, 1013-1018.
29. HERRERA, D.G. & ROBERTSON, H.A. (1996). Activation of c-fos in the brain. Progress Neurob., 50, 83-107.
30. HÖLSCHER, C. & ROSE, S.P. (1993). Inhibiting synthesis of the putative retrograde messenger nitric oxide results in amnesia in a passive avoidance task in the chick. Brain Res., 619, 189-194.
31. HÖLSCHER, C., MCGLINCHEY, L., ANWYL, R. & ROWAN, M.J. (1995). 7-Nitro indazole, a selective neuronal nitric oxide synthase inhibitor in vivo, impairs spatial learning in the rat. Learn. Memory, 2, 267-278.
32. 2+ in cultured rat forebrain neurones. Brain Res., 592, 310-316.
33. HUGHES, P. & DRAGUNOV, M. (1995). Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol. Rev., 47, 133-178.
34. IGNARRO, L. & MURAD, F. (1995). Nitric oxide: Biochemistry, Molecular Biology and Therapeutic Implications. San Diego: Academic Press.
35. (')-nitro-L-arginine in rats impairs learning in a 14-unit T-maze. Eur. J. Pharmacol., 341, 11-16.
36. INGRAM, D.K , SPANGLER. E.L., MEYER, R.C. & LONDON, E.D. (1998b). Learning in a 14-unit T-maze is impaired in rats following systemic treatment with N-W-nitro-L-arginine. Eur. J. Pharmacol., 341, 1-9.
37. JACKSON, D.M., JOHANSSON, C., LINDGREN, L.M. & BENGTSSON, A. (1994). Dopamine receptor antagonists block amphetamine and phencyclidine-induced motor stimulation in rats. Pharmacol. Biochem. Behav., 48, 465-471.
38. JENTSCH, J.D., REDMOND, D.E., ELSWORTH, J.D.. TAYLOR, J.R., YOUNGREN, K.D. & ROTH, R.H. (1997). Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. Science, 277, 953-955.
39. JOHANSSON, C., DEVENEY, A.M , REIF. D. & JACKSON, D M. (1999). The neuronal selective nitric oxide inhibitor AR-R 17477, blocks some effects of phencyclidine, while having no observable behavioural effect when given alone. Pharmacol. Toxicol., 84, 226-233.
40. JOHANSSON, C., JACKSON, D.M. & SVENSSON. L. (1997). Nitric oxide synthase inhibition blocks phencyclidine-induced behavioural effects on prepulse inhibition and locomotor activity in the rat. Psychopharmacology, 131, 167-173.
41. JOHANSSON, C., MAGNUSSON, O., DEVENEY, A.M., JACKSON, D.M., ZHANG, J., ENGEL, J.A. & SVENSSON, L. (1998). The nitric oxide synthase inhibitor, L-NAME, blocks certain phencyclidine-induced but not amphetamine-induced effects on behaviour and brain biochemistry in the rat. Prog. Neuropsyhopharmacol. Biol. Psychiatry, 22, 1341-1360.
42. KRYSTAL, J.H., KARPER, L., BANNETT, A., ABI-SAAB, D., SOUZA, C., ABI-DARGHAM, A. & CHARNEY, D. (1995). Modulating ketamine-induced thought disorder with lorazepam and haloperidol in humans. Schizophrenia Res., 15, 156.
43. LIDOW, M.S., WILLIAMS, G.V. & GOLDMAN-RAKIC, P.S. (1998). The cerebral cortex: a case for common site of action of antipsychotics. Trends Pharmacol. Sci., 19, 136-140.
44. LIN, A.M.Y., KAO, L.S. & CHAI, C.Y. (1995). Involvement of nitric oxide in dopaminergic neurotransmission in rat striatum an in vivo electrochemical study. J. Neurochem., 65, 2043-2049.
45. LIU, Q.S., JIA, Y.S. & JU, G. (1997). Nitric oxide inhibits neuronal activity in the supraoptic nucleus of the rat hypothalamic slices. Brain Res. Bull., 43, 121-125.
46. MAREN, S. (1998). Effects of 7-nitroindazole, a neuronal nitric oxide synthase (nNOS) inhibitor, on locomotor activity and contextual fear conditioning in rats. Brain Res., 804, 155-158.
47. MELTZER, H.Y. & STAHL, S.M. (1976). The dopamine hypothesis of schizophrenia: a review. Schizophrenia Bull., 2, 19-76.
48. MEYER, R.C., SPANGLER, E.L., PATEL, N , LONDON, E.D. & INGRAM, D.K. (1998). Impaired learning in rats in a 14-unit T-maze by 7-nitroindazole, a neuronal nitric oxide synthase inhibitor, is attenuated by the nitric oxide donor, molsidomine. Eur. J. Pharmacol., 341, 17-22.
49. MOGHADDAM, B. & ADAMS, B.W (1998). Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science, 281, 1349-1352.
50. NAGAO, T., OHSHIMO, T., MITSUNOBU, K., SATO, M. & OTSUKI, S. (1979). Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in chronic schizophrenic patients with tardive dyskinesia or drug-induced tremor. Biol. Psychiatry, 14, 509-523.
51. NAKAMURA, T., YAMADA, K., HASEGAWA, T. & NABESHIMA, T. (1995). Possible involvement of nitric oxide in quinolinic acid-induced convulsion in mice. Pharmacol. Biochem. Behav., 51, 309-312.
52. NÄKKI, R., SHARP, F.R., SAGAR, S.M. & HONKANIEMI, J. (1996). Effects of phencyclidine on immediate early gene expression in the brain. J. Neurosci. Res., 45, 13-27.
53. NODA, Y., YAMADA, K., FUROKAWA, H. & NABESHIMA, T. (1995). Involvement of nitric oxide in phencyclidine-induced hyperlocomotion in mice. Eur. J. Pharmacol., 286, 291-297.
54. NODA, Y., YAMADA, K., KOMORI, Y., SUGIHARA, H., FURUKAWA, H. & NABESHIMA, T. (1996). Role of nitric oxide in the development of tolerance and sensitization to behavioural effects of phencyclidine in mice. Br. J. Pharmacol., 117, 1579-1585.
55. O'DELL, T.J., HAWKINS, R.D., KANDEL, E R. & ARANCIO, O. (1991). Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger. Proc. Natl. Acad. Sci. U.S.A., 88, 11285-11289.
56. OGREN, S.O. & GOLDSTEIN, M. (1994). Phencyclidine and dizocilpine-inded hyperlocomotion are differentially mediated. Neuropsychopharmacology, 11, 167-177.
57. OKUBO, Y., SUHARA, T., SUZUKI, K., KOBAYASHI, K., INOUE, O., TERESAKI, O., SOMEYA, Y., SASSA, T., SUDO, Y., MATSUSHIMA, E., IYO, M., TATENO, Y. & TORU, M. (1997). Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature, 385, 634-636.
58. OSAWA, Y. & DAVILA, J.C. (1993). Phencyclidine, a psychotomimetic agent and drug of abuse, is a suicide inhibitor of brain nitric oxide synthase. Biochem. Biophys. Res. Comm., 194, 1435-1439.
59. PAXINOS, G. & WATSON, C. (1998). The Rat Brain in Stereotaxic Coordinates. San Diego: Academic Press.
60. SAGAR, S.M., SHARP, F.R. & CURRAN, T. (1988). Expression of c-fos protein in the brain: metabolic mapping at the cellular level. Science, 240, 1328-1331.
61. SANDI, C., VENERO, C. & GUAZA, C. (1995). Decreased spontaneous motor activity and startle response in nitric oxide synthase inhibitor-treated rats. Eur. J. Pharmacol., 277, 89-97.
62. SCHUMAN, E.M. & MADISON, D.V (1991). A requirement for the intercellular messenger nitric oxide in long-term potentiation. Science, 254, 1503-1506.
63. SEEMAN, P., LEE, T., CHAU-WONG, M. & WONG, K. (1976). Antipsychotic drug doses and neuroleptic dopamine receptors. Nature, 261, 717-719.
64. SHARP, J.W. (1997). Phencyclidine (PCP) acts at σ sites to induce c-fos gene expression. Brain Res., 758, 51-58.
65. SILBERSWEIG, D. & STERN, E. (1996). Functional neuroimaging of hallucinations in schizophrenia toward an integration of bottom-up and top-down approaches. Mol. Psychiatry, 1, 367-375.
66. STEINPREIS, R.E. (1996). The behavioural and neurochemical effects of phencyclidine in humans and animals: some implications for modelling psychosis. Behav. Brain Res., 74, 45-55.
67. STEINPREIS, R.E., SOKOLOWSKI, J.D., PAPANIKOLAOU, A. & SALAMONE, J.D. (1994). The effects of haloperidol and clozapine on PCP-and amphetamine-induced suppression of social behavior in the rat. Pharmacol. Biochem. Behav., 47, 579-585.
68. SZABO, C. (1996). Physiological and pathophysiological roles of nitric oxide in the central nervous system. Brain Res. Bull., 41, 131-141.
69. TAMMINGA, C.A. (1998). Schizophrenia and glutamateric transmission. Crit. Rev. Neurobiol., 12, 21-36.
70. TAMMINGA, C.A. (1999). Glutamatergic aspects of schizophrenia. Br. J. Psychiatry, 174, 12-15.
71. THORNBERG, S.A. & SAKLAD, S.R. (1996). Review of NMDA receptors and phencyclidine model of schizophrenia. Pharmacotherapy, 16, 82-93.
72. TORU, M., KURAMAJI, A. & ISHIMARU, M. (1994). Excitatory amino acids: implications for psychiatric disorders research. Life Sci., 55, 1683-1699.
73. UMINO, A., NISHIKAWA, T. & TAKAHASHI, K. (1995). Methamphetamine-induced nuclear c-fos in rat brain regions. Neurochem. Int., 26, 85-90.
74. VERMA, A. & MOGHADDAM, B. (1996). NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation of performance in rats: modulation by dopamine. J. Neurosci., 16, 373-379.
75. VOLKE, V., SOOSAAR, A., KÒKS, S , BOURIN, M , MÄNNISTÖ, P.T. & VASAR, E. (1997). 7-Nitroindazole, a nitric oxide synthase inhibitor, has anxiolytic-like properties in exploratory models of anxiety. Psychopharmacology, 131, 399-405.
76. WARD, L., MASON, S.E. & ABRAHAM, W.C. (1990). Effects of the NMDA antagonists CPP and MK-801 on radial arm maze performance in rats, Pharmacol. Biochem. Behav., 35, 785-790.
77. YAMADA, K., NODA, Y., HASEGAWA, T., KOMORI, Y., NIKAI, T., SUGIHARA, H. & NABESHIMA, T. (1996). The role of nitric oxide in dizocilpine-induced impairment of spontaneous alteration behaviour in mice. J. Pharmacol. Exp. Ther., 276, 460-466.
78. YAMADA, K., NODA, Y., NAKAYAMA, S., KOMORI, Y., SUGIHARA, H., HASEGAWA, T. & NABESHIMA, T. (1995). Role of nitric oxide in learning and memory and in monoamine metabolism in the rat brain. Br. J. Pharmacol., 115, 852-858.
79. YANG, Q., MOROJI, T., TAKAMATSU, Y , HAGINO, Y. & OKUWA, M. (1991). The effects of intraperitoneally administered phencyclidine on the central nervous system: behavioural and neurochemical studies. Neuropeptides, 19, 77-90.
80. ZOU, L.B., YAMADA, K., TANAKA, T , KAMEYADA, T. & NABESHIMA, T. (1998). Nitric oxide synthase inhibitors impair reference memory formation in a radial arm maze task in rats. Neuropharmacology, 37, 323-330.